この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
ビジネス · 2008/6/121 分で読めます
Hospira, Inc., et al.; Withdrawal of Approval of One New Drug Application and Two Abbreviated New Drug Applications
ローカル自動翻訳 · 情報源の原言語
概要
The Food and Drug Administration (FDA) is withdrawing approval of one new drug application (NDA) and two abbreviated new drug applications (ANDAs) for edetate disodium injection. The holders of these applications have agreed in writing to permit FDA to withdraw approval of the applications and have waived their opportunity for a hearing.
情報源の原言語: Federal Register — Food and Drug Administration原文の発表を開く →